Two experimental HCV drugs show promise in small study
18 February 2012
University of Michigan researchers said a study using the experimental drugs asunaprevir and daclatasvir, along with the standard therapy of peginterferon alfa-2a and ribavirin, eliminated the hepatitis C virus in all 10 trial participants who had not responded to traditional treatment. 
| Previous: Traumatic brain injury in young may lead to lower IQ for at least 10 years | Article Explores Workings Of Enteric Nervous System Next: |
|---|
Comments